게르마늄 강화효모의 마우스에서의 암세포 억제 및 대식세포, NK 세포, B 세포의 활성화에 관한 연구 = Germanium-Fortified Yeast Activates Macrophage, NK Cells and B Cells and Inhibits Tumor Progression in Mice

참고문헌 (Reference)

1 Lee, J. S, "ral single-and repeated-dose oxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeasts, in rats" 29 : 541-553, 2004

2 30 Wright, "Tumor promoting phorbol ester stimulated C3b and C3b’ receptor-mediated phagocytosis in cultured human monocytes" 1149-1162, 1982

3 9 Goodman, "Therapeutic effects of organic germanium" 207-215, 1988

4 Badawi, A. M, "Synthesis and immunomodulatory activity of some novel amino acid germinates" 4 : 107-113, 2007

5 24 Suzuki, "Suppression of tumor growth by isolated peritoneal macrophages from mice treated with carboxyethylgermanium sesquioxide" 2122-132 2128, 1985

6 D′Onofrio, "Role of biological response modifiers in immunochemotherapy of solid tumors and retroviral-induced leukemia" 6 385-395, 1990

7 19 Okada, "Renal railure caused by long-term use of a germanium preparation as an elixir" 219-224, 1989

8 Bigitta, E. L, "Renal and other organ failure caused by germanium intoxication" 14 : 2464-2468, 1999

9 23 Sohn, "Process for preparing S"

10 27 Swenson, "Phagocytosis of Cryptococcus neoformans by normal and thioglycolateactivated macrophages" 714-720, 1978

11 Lee, J. S, "Oral single-and repeated-dose oxicity studies on Geranti Bio-Ge yeast, organic germanium fortified yeasts, in dogs" 29 : 555-569, 2004

12 Lee, S. H, "Oral repeated-dose toxicity studies especially in the liver and kidney of rats administered with organic germanium-fortified yeasts" 11 : 115-119, 2006

13 I, "New approaches to using spent brewer’s yeast" 18 (18): 5-8, 1980

14 22 Schauss,A.G, "Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide" 29 : 267-280, 1991

15 Ohashi, "Multidisciplinary treatment of head and neck cancer using BCG and GE-132 as biologic response modifiers" 7 30-432 38, 1994

16 Arai, "Induction of interferon production by NK cells by organogermanium compound" kuwa : 17 69-132 76, 1987

17 Suzuki, "Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge- 132" immu (immu): 2 65-74, 1985

18 I, "Increased oxygen species generation in blood monocytes of asthmatic patients" 29 1161-1166, 1992

19 25 Suzuki, "Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide" 479-132 483, 1985

20 Tao, S. H., "Hazard assessment of germanium supplements" 211 Regulatory Toxicology and Pharmacology : 25-, 1997

21 Lee, S. H, "Efficacy study of activation on macrophage in germanium-fortified yeast" 48 : 246-251, 2005

22 Lee, S. H, "Effects of germanium-fortified yeast on the serum lipids and immune cell subset" 35 : 1-7, 2006

23 Joo, S. S, "Effect of Geranti Bio-Ge yeast, a dried yeast containing biogermanium, on the production of antibodies by B cells" 6 : 86-92, 2006

24 Watanabe, "Effect of Ge-132 products and related synthetic compounds" 1 536-539, 1981

25 A, "Dual role for alveolar macrophages in humoral and cell-mediated immune response evidence for suppressor and enhancing functions" 20 205-217, 1981

26 5 Faubert,G.M, "Depression of the plaque-forming cells to sheep red blood cells by the new-born larvae of Trichinella spiralis" 30 : 485-489, 1976

27 U, "Cytoadherence characteristics of rosette-forming Plasmodium falciparum" 21 4483-4490, 1992

28 26 Suzuki, "Cooperation of lymphokines and macrophages in expression of antitumor activity of carboxyehtylgermanium sesquioxide" 177-132 182, 1986

29 Lee, J. H, "Anti-inflammatory effect of germaniumconcentrated yeast against paw oedema is related to the inhibition of arachidonic acid release and prostaglandin E2 production in RBL 2H3 cells" 25 : 129-134, 2005